 |
Minimale Einzahlung $50 Exklusive Aktion |
Unser Ergebnis |
0% Kommission |
Are you looking to buy Vertex Pharmaceuticals stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:VRTX! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Vertex Pharmaceuticals stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 12 years of age or older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator, or CFTR, gene. Its pipeline includes Pipeline for Alpha-1 antitrypsin deficiency that is in Phase 2 clinical trial; VX-864, a second investigational small molecule corrector for the treatment of AAT deficiency, which is in Phase 1 clinical trial; and VX-147 that completed a Phase 1 clinical trial for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. Vertex Pharmaceuticals Incorporated has collaborations with CRISPR Therapeutics AG; Arbor Biotechnologies, Inc.; Moderna, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany; X-Chem, Inc.; Janssen Pharmaceuticals, Inc.; Merck KGaA; Kymera Therapeutics; Ribometrix, Inc.; Molecular Templates, Inc.; and Affinia Therapeutics. The company was founded in 1989 and is headquartered in Boston, Massachusetts.
Durchschnittliches Volumen
2.19 million shs
MARKTKAPPE
$56.09 billion
Börse
NASDAQ
Kaufen Sie diese Aktie!
|
NAME
|
TICKER
|
INDUSTRIE
|
SECTOR
|
VOLUME
|
KAUFEN SIE DIESE AKTIE JETZT
|
|---|---|---|---|---|---|
|
NASDAQ:VRTX
|
Pharmazeutische Präparate
|
Medizinisch
|
49,205 shs
|
Below is a quick guide on how to buy NASDAQ:VRTX stocks safe, fast and around the world in less than five minutes.
Schritt 1: Eröffnen Sie ein Konto bei eToro – eToro is the best broker to buy Vertex Pharmaceuticals shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Schritt 2: Laden Sie Ihre ID hoch - Gemäß den KYC-Vorschriften wird eToro Sie bitten, eine Kopie Ihres Reisepasses oder Führerscheins hochzuladen.
Schritt 3: Geld einzahlen - Zahlen Sie etwas Geld auf Ihr neu eingerichtetes eToro Konto ein. Sie können zwischen Banküberweisung, E-Wallet, Debit-/Kreditkarte oder Paypal wählen.
Schritt 4: Buy Vertex Pharmaceuticals – Search for “”NASDAQ:VRTX”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Vertex Pharmaceuticals stocks with 0% commission!.
1 | | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
27 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Vertex Pharmaceuticals in the last year. There are currently 4 hold ratings, 22 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should “buy” Vertex Pharmaceuticals stock.
Wall Street analysts have given Vertex Pharmaceuticals a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Vertex Pharmaceuticals wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
2 |  | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
3 |  | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:VRTX stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Vertex Pharmaceuticals stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Vertex Pharmaceuticals stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Da es sich bei eToro um eine regulierte Plattform handelt, müssen Sie das KYC-Verfahren abschließen. Dies ist gängige Praxis und dauert nur ein paar Minuten. Sie müssen einen Lichtbildausweis (Reisepass, Führerschein) und einen Adressnachweis (Stromrechnung, Kontoauszug) vorlegen.
Sobald Sie sich angemeldet und Ihr Konto verifiziert haben, müssen Sie Geld einzahlen. eToro akzeptiert Kredit-/Debitkarten, Banküberweisungen und auch E-Wallets. Was auch immer Sie bevorzugen, es wird etwas für Sie dabei sein.
Now that you’ve funded your eToro account, just type “NASDAQ:VRTX stocks" in die Suchleiste am oberen Rand des Bildschirms ein und drücken Sie auf "Handeln".
All that’s left is to buy some NASDAQ:VRTX stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:VRTX is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Vertex Pharmaceuticals stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Vertex Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Vertex Pharmaceuticals.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) issued its quarterly earnings results on Sunday, January, 31st. The pharmaceutical company reported $2.51 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.59 by $0.08. Vertex Pharmaceuticals had a trailing twelve-month return on equity of 28.55% and a net margin of 38.51%. During the same quarter in the prior year, the firm posted $1.70 EPS.
View Vertex Pharmaceuticals’ earnings history.
Vertex Pharmaceuticals’ stock was trading at $220.34 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, VRTX stock has decreased by 1.5% and is now trading at $217.14.
Vertex Pharmaceuticals declared that its board has approved a stock buyback plan on Wednesday, July 31st 2019, which allows the company to buyback $500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase up to 1.2% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s leadership believes its shares are undervalued.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:VRTX stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Mehr als 95% der Kundengelder werden offline, in kalten Lagern, aufbewahrt, was für jeden Broker, der Ihr Vermögen verwaltet, entscheidend ist. Unabhängig davon, wie sicher eine Plattform sein soll, empfehlen wir die Verwendung von 2FA, um eine zusätzliche Sicherheitsebene für Ihr Konto zu schaffen.
eToro bietet Nutzern eine Reihe von Funktionen, um so schnell wie möglich mit dem Investieren zu beginnen. Es gibt eine relativ einzigartige Funktion namens Copy Trading, mit der Sie ein passives Einkommen erzielen können, indem Sie erfahrene Händler spiegeln. So können Sie schnell Gewinne erzielen und erhalten ein besseres Verständnis für die Strategien, die von Profis verwendet werden. Außerdem können Sie bei eToro in verwaltete Portfolios investieren. Ein verwaltetes Portfolio besteht aus einer Vielzahl ähnlicher Vermögenswerte, die in Gruppen zusammengefasst sind. Wenn Sie bereits über Handelserfahrung verfügen, können Sie auch in andere Märkte als Aktien investieren, da eToro den Handel mit ETFs, Rohstoffen, Kryptowährungen und Indizes ermöglicht. Wenn Sie bereits außerhalb des Aktienmarktes investieren, kann dies sehr nützlich sein, da Sie so alle Ihre Investitionen an einem einzigen Ort verwalten können.
27 brokerages have issued twelve-month price targets for Vertex Pharmaceuticals’ stock. Their forecasts range from $250.00 to $347.00. On average, they expect Vertex Pharmaceuticals’ stock price to reach $293.44 in the next year. This suggests a possible upside of 35.1% from the stock’s current price.
View analysts’ price targets for Vertex Pharmaceuticals or view top-rated stocks among Wall Street analysts.
Vertex Pharmaceuticals saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 3,250,000 shares, an increase of 21.3% from the December 15th total of 2,680,000 shares. Based on an average daily trading volume, of 2,110,000 shares, the short-interest ratio is presently 1.5 days.
View Vertex Pharmaceuticals’ Short Interest.
CFDs sind komplexe Instrumente und bergen aufgrund der Hebelwirkung ein hohes Risiko, schnell Geld zu verlieren. 68% der Konten von Kleinanlegern verlieren Geld beim Handel mit CFDs bei diesem Anbieter. Sie sollten sich überlegen, ob Sie verstehen, wie CFDs funktionieren und ob Sie das hohe Risiko, Ihr Geld zu verlieren, eingehen können.
Vertex Pharmaceuticals’ management team includes the following people:
Dr. Jeffrey Marc Leiden, Exec. Chairman (Age 65, Pay $4.88M)
Dr. Reshma Kewalramani, CEO, Pres & Director (Age 48, Pay $2.03M)
Mr. Charles F. Wagner Jr., Exec. VP & CFO (Age 53, Pay $1.66M)
Mr. Amit K. Sachdev, Exec. VP & Chief Patient Officer (Age 53, Pay $1.41M)
Mr. Stuart A. Arbuckle, Exec. VP & Chief Commercial Officer (Age 55, Pay $2.07M)
Mr. Paul M. Silva, Sr. VP & Corp. Controller (Age 55, Pay $833.97k)
Dr. David M. Altshuler, Exec. VP of Global Research & Chief Scientific Officer (Age 56)
Mr. Mike Tirozzi, SVP and Chief Information & Data Officer
Mr. Michael J. Parini, Exec. VP & Chief Admin., Legal and Bus. Devel. Officer (Age 46)
Mr. Michael Partridge, Sr. VP of Investor Relations
31 employees have rated Vertex Pharmaceuticals CEO Reshma Kewalramani on Glassdoor.com. Reshma Kewalramani has an approval rating of 76% among Vertex Pharmaceuticals’ employees.
Some companies that are related to Vertex Pharmaceuticals include Amgen (AMGN), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Biogen (BIIB), Seagen (SGEN), Alexion Pharmaceuticals (ALXN), Exact Sciences (EXAS), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), Novavax (NVAX), BioMarin Pharmaceutical (BMRN), Repligen (RGEN), Neurocrine Biosciences (NBIX), Ionis Pharmaceuticals (IONS) and United Therapeutics (UTHR).
View all of VRTX’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other Vertex Pharmaceuticals investors own include NVIDIA (NVDA), Companhia de Saneamento Básico do Estado de São Paulo – SABESP (SBS), Alibaba Group (BABA), Advanced Micro Devices (AMD), Gilead Sciences (GILD), Micron Technology (MU), salesforce.com (CRM), Netflix (NFLX), Intel (INTC) and PayPal (PYPL).
1 | | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
Vertex Pharmaceuticals trades on the NASDAQ under the ticker symbol “VRTX.”
Vertex Pharmaceuticals’ stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.33%), FMR LLC (5.05%), Jennison Associates LLC (1.44%), California Public Employees Retirement System (0.81%), Swiss National Bank (0.56%) and Sumitomo Mitsui Trust Holdings Inc. (0.50%). Company insiders that own Vertex Pharmaceuticals stock include Amit Sachdev, Bruce I Sachs, Charles F Wagner Jr, David Altshuler, Jeffrey M Leiden, Margaret G Mcglynn, Michael Parini, Ourania Tatsis, Paul M Silva, Reshma Kewalramani, Sangeeta N Bhatia, Stuart A Arbuckle, William D Young and Yuchun Lee.
View institutional ownership trends for Vertex Pharmaceuticals.
VRTX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, BlackRock Inc., First Trust Advisors LP, AMF Pensionsforsakring AB, Strs Ohio, State of Michigan Retirement System, AJO LP, and Robeco Institutional Asset Management B.V.. Company insiders that have sold Vertex Pharmaceuticals company stock in the last year include Amit Sachdev, Bruce I Sachs, Charles F Wagner Jr, Jeffrey M Leiden, Michael Parini, Ourania Tatsis, Paul M Silva, Reshma Kewalramani, Sangeeta N Bhatia, Stuart A Arbuckle, and Yuchun Lee.
View insider buying and selling activity for Vertex Pharmaceuticals or view top insider-selling stocks.
VRTX stock was purchased by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Manning & Napier Group LLC, Candriam Luxembourg S.C.A., Jennison Associates LLC, Victory Capital Management Inc., Swiss National Bank, LVM Capital Management Ltd. MI, and LA Financiere DE L Echiquier.
View insider buying and selling activity for Vertex Pharmaceuticals or or view top insider-buying stocks.
Shares of VRTX can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interaktive Makler Bewertung, eToro Überprüfung, DEGiro Rückblick, AvaTrade Bewertung, IG Markets Rückblick, IC Märkte Rückblick, CMC Markets Rückblick, Admiral Markets Rückblick und viele mehr. Lesen Sie eine der Bewertungen, um alles über den Broker zu erfahren, und beginnen Sie jetzt mit dem Kauf von Aktien.
One share of VRTX stock can currently be purchased for approximately $217.14.
Wir von Reportlab.org möchten sicherstellen, dass Sie alle wichtigen Informationen über Aktien kaufen. Wir bieten Ihnen die besten Leitfäden zum Thema Börse mit persönlichen Bewertungen, Hintergrundinformationen, Plattformbewertungen, Anleitungen und mehr. Möchten Sie weitere Informationen erhalten? Dann schauen Sie sich die OTC-Aktien, NASDAQ-Aktien, NYSE-Aktien, LON-Aktien, FRA-Aktien, ETR-Aktien, EPA-Bestände, TSX-Aktien oder Amex Aktien. Sie suchen nach detaillierteren Informationen wie 5g Vorräte, Biotech-Aktien, Goldvorräte und andere Informationen aus unserem Reportlab.
How can you buy Vertex Pharmaceuticals stock on the internet?
You can easily buy Vertex Pharmaceuticals stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Eine weitere Option ist die Nutzung eines regulierten Brokers wie IC-Märkte oder Interaktive Makler. You can an account with these brokers and start buying or trading NASDAQ:VRTX stocks in a safe and complete environment to trade in.
Where to buy Vertex Pharmaceuticals stock?
You will first want to find a licensed broker that supports NASDAQ:VRTX stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:VRTX stocks in a safe and complete environment.
Is NASDAQ:VRTX stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:VRTX stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Vertex Pharmaceuticals stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:VRTX is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Vertex Pharmaceuticals stock.
How do you trade Vertex Pharmaceuticals stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Vertex Pharmaceuticals stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:VRTX stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Vertex Pharmaceuticals stock?
To sell your NASDAQ:VRTX stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Vertex Pharmaceuticals stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:VRTX stock.
Stephen kennt sich gut mit Finanzprodukten aus und hat insbesondere eine große Leidenschaft für die Aktienmärkte und ihre Teilnehmer. Wir hoffen, dass die bereitgestellten Informationen Ihnen helfen werden. Ist Ihnen etwas nicht ganz klar? Bitte hinterlassen Sie Ihre Fragen oder Kommentare unten auf der Seite.
| Unser Ergebnis ★★★★★ | |
| Unser Ergebnis ★★★★★ | |
| Unser Ergebnis ★★★★★ |
Newsletter
Neueste Nachrichten
| |
Unser Ergebnis |
0% Kommission |
Alle EPA-Aktien Weitere Informationen EPA-Aktien Was ist die Pariser Börse (EPA)? Jetzt
Aktien & Krypto-Daten in Echtzeit
Benachrichtigungen, Tipps & Neuigkeiten
Beste Aktien & Krypto-Führer
Online Broker & Börse Bewertungen
Reportlab Finanzen ist eine rein informative Website und stellt in keinem Fall eine Anlageberatung dar. Alle Investitionen sind mit Risiken verbunden und Sie können Ihre gesamten Investitionen verlieren. Investieren Sie kein Geld, das Sie sich nicht leisten können, zu verlieren.
Reportlab Finanzen
38 Holburn Lane
Heckfield Green
IP21 0UB
Vereinigtes Königreich
Copyright © 2022 Reportlab.Finance | Alle Rechte vorbehalten.
